News

Curis to Announce Q1 2025 Financial Results and Call Details

Curis to Announce Q1 2025 Financial Results and Call Details

Curis Prepares for First Quarter 2025 Financial Report

Curis, Inc. (NASDAQ: CRIS), a prominent biotechnology firm, is gearing up to unveil its financial and operational metrics for the first quarter of 2025. The announcement will occur on an upcoming Tuesday at 8:00 a.m. ET. Following this release, the management team is set to host an informative conference call at 8:30 a.m. ET, allowing for in-depth discussions surrounding the results.

Joining the Conversation

Stakeholders eager to participate in the call can easily connect by dialing the designated numbers. For those in the United States, the number is (800)-836-8184, while international participants can reach out at (646)-357-8785. Additionally, the event will be accessible via a live audio webcast, making it convenient for viewers worldwide to engage in the company's developments.

Webcast Access and Replay Information

Those who wish to tune in to the live webcast can find it on the Curis website under the events and presentations section. Furthermore, for individuals unable to join at the time of the event, a replay will be available on the Curis website, ensuring that all interested parties can catch up on the discussion and insights shared during the call.

About Curis and Its Innovations

Curis is dedicated to pioneering advances in the biotechnology realm, particularly through its investigational drug emavusertib (CA-4948). This orally taken small molecule functions as an IRAK4 inhibitor and is currently in clinical trials. Emavusertib is being assessed for various health conditions: it’s part of the ongoing Phase 1/2 TakeAim Lymphoma study for patients experiencing relapsed or refractory primary central nervous system lymphoma (PCNSL) and is also being examined as a monotherapy in the Phase 1/2 TakeAim Leukemia study targeting relapsed/refractory acute myeloid leukemia (AML). In addition, it is part of a frontline treatment strategy combining with venetoclax and azacitidine to aid patients with AML.

Regulatory Designations

Emavusertib has received the esteemed Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its applications involving PCNSL, AML, and myelodysplastic syndromes (MDS). This designation is pivotal for the drug’s development and potential market success, marking it as a promising option for addressing significant unmet medical needs.

Curis Collaboration and License

The company has a notable collaboration with Aurigene, granting them exclusive licensing rights to develop emavusertib. Additionally, Curis had previously licensed its rights to another drug, Erivedge®, to Genentech, which is actively commercializing it for advanced basal cell carcinoma treatment.

Frequently Asked Questions

What is the purpose of the upcoming conference call?

The conference call aims to discuss Curis's first quarter 2025 financial results and provide insights into the company's current operations and future outlook.

How can I listen to the financial call?

You can listen to the financial call by dialing the provided numbers for your location or through the live audio webcast available on the Curis website.

What innovations is Curis focusing on?

Curis is focusing on the development of emavusertib, an IRAK4 inhibitor, currently undergoing trials for several hematological malignancies.

Where can I find the replay of the call?

The replay of the conference call will be available on the Curis website under the events and presentations section.

Is Curis involved in collaborations?

Yes, Curis collaborates with Aurigene, holding exclusive rights to develop and commercialize emavusertib.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 136

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 187

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
PenFed Fuels Aggie Spirit with Blackout Game Activation

Updated Category News Views 196

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 115

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading
ACME's AI Innovation Shakes Up Filmmaking Scene

Updated Category News Views 87

The Game-Changer in Virtual Production You ever hear about the Grey Box™ phenomenon? Sounds like a sci-fi gizmo, right? Turns out, it's the real deal and ACME Media's been riding this revolutionary wave straight to the top of the film industry ladder. Their approach with this AI-driven gizmo isn't just about cutting-edge tech wizardry—it's reimagining how we shoot...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 163

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 139

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Terra Kaffe's Big Win with Oprah's Endorsement

Updated Category News Views 109

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Continue Reading
Shorenstein Expands in Dallas: Strategic Play or Risk?

Updated Category News Views 127

Shorenstein's recent acquisition of International Plaza 3 isn't just about adding another high-rise to their portfolio; it's a stake in the ground, a doubling down on the Dallas real estate market. With its aim sharply set on the Lower Tollway submarket, Shorenstein is showing confidence, but the big question remains—are they spot on or walking the razor's edge?...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 60

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

The Brattle Group Enhances Services with New Principal

Updated Category News Views 168

The Brattle Group Enhances Services with New Principal The Brattle Group is pleased to announce the addition of Hans Weemaes as a Principal in its Financial Services & Markets and Regulatory Investigations & Enforcement practices. With an impressive background as a former economist for a federal treasury, Mr. Weemaes carries over 20 years of extensive experience in...

Continue Reading
Lumen and AWS Unite to Advance Generative AI Through Networks

Updated Category News Views 263

Lumen and AWS Join Forces in Generative AI Development Lumen Technologies (NYSE: LUMN) has announced a strategic collaboration with Amazon Web Services (AWS), an Amazon.com company (NASDAQ: AMZN), aiming to enhance network operations and delivery capabilities. This partnership is set against the backdrop of expanding AI-driven services that demand efficient and robust...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 46

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Modernization: Strengthening Ties Between China and Africa

Updated Category News Views 64

Modernization: Strengthening Ties Between China and Africa Recently, China Everything released an engaging short video titled "A shared path to modernization." This video highlights the successful collaboration between China and Africa, showcasing the strong friendship that has developed between the people of these two regions. The Unity of Aspirations As the largest...

Continue Reading
Okeanis Eco Tankers Announces Dividend Details for Shareholders

Updated Category News Views 129

Okeanis Eco Tankers Declares Dividend for Common Shares Okeanis Eco Tankers Corp. (NYSE: ECO / OSE: OET) has announced a significant dividend for its shareholders. The board of directors has officially declared a dividend on its common shares, representing a fruitful opportunity for investors as they participate in the company's success. This dividend is a reflection of...

Continue Reading